Stichting Radboud University Medical Center

• Improving inpatient GHB detoxification with baclofen Not authorised
  2023-506167-34-00 Phase II 1 country BACLOFEN
• Pragmatic trial on the safety and tolerability of an optimized dose of rifampicin in tuberculosis patients Recruiting
  2023-509885-39-00 Phase III 3 countries
• Improving inpatient GHB detoxification with baclofen Recruiting
  2023-506167-34-02 Phase II 1 country BACLOFEN; SODIUM OXYBATE
• Management of Parkinson's disease if levodopa is broken down prematurely Recruiting
  2024-510629-24-00 Phase II 1 country APOMORPHINE HYDROCHLORIDE HEMIHYDRATE; BENSERAZIDE HYDROCHLORIDE, LEVODOPA; DOMP…
• Pred Forte® versus placebo eye drops in chronic central serous chorioretinopathy trial (PICS trial) Recruiting
  2024-511575-15-00 Phase III 1 country DEXTRAN 70, HYPROMELLOSE; PREDNISOLONE ACETATE
• PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy: a Randomized… Recruiting
  2023-504144-33-01 Phase III/IV 2 countries COLISTIN SULFATE, TOBRAMYCIN; NYSTATIN
• Methylphenidate in KBG syndrome Recruiting
  2023-506202-40-01 Phase IV 1 country METHYLPHENIDATE HYDROCHLORIDE
• Efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled clinical trial. (EDIT-CAS) Recruiting
  2023-507782-25-00 Phase II/III 1 country ACETYLCHOLINE CHLORIDE; BOSENTAN; BOSENTAN MONOHYDRATE
• Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled, superiority… Recruiting
  2023-504143-14-00 Phase IV 1 country METAMIZOLE SODIUM MONOHYDRATE
• Predicting the effect of blood pressure lowering medication using Multi-Omics, a biomarker profile based on blood and urine analyses Recruiting
  2023-505239-10-00 Phase IV 1 country AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL; OLMESARTAN MEDOXOMIL, AML…
• Phase II Dutasteride in combination with CAB vs CAB in SDC (DUCT) Recruiting
  2022-500745-24-00 Phase II/III 1 country BICALUTAMIDE; DUTASTERIDE; GOSERELIN ACETATE
• Pancreatitis and early omega-3-fatty acid infusion for reduction of organ failure and mortality. Recruiting
  2023-505220-57-03 Phase III 2 countries GLYCEROL, HIGHLY REFINED FISH OIL, PURIFIED EGG PHOSPHOLIPIDS
• Effect of different drugs on the immune response during inflammation: the DEDICATE-LPS study Ended
  2023-506556-24-00 Phase II 1 country ANAKINRA; ATROPINE SULFATE MONOHYDRATE; DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLY…
• A phase 4, randomised vaccination study in healthy adults to investigate the effects of acellular pertussis vaccine on colonisation with Bor… Ended
  2023-508416-35-00 Phase IV 1 country AZITHROMYCIN; DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FIL…
• rIFN-Gamma 1b in Candidemia Ended
  2024-510816-55-00 Phase II 4 countries RECOMBINANT HUMAN INTERFERON GAMMA 1B
• Study on PhArmacokiNetics of first liNe Antiretrovirals in healthy Breastfeeding volunteers or women living with HIV and already on antiretr… Ended
  2023-510232-36-00 Phase I (Other) 1 country
• Rivaroxaban sotorasib interaction study Ended
  2023-505557-41-00 Phase IV 1 country RIVAROXABAN; SOTORASIB
• Intradermal administration of a COVID-19 mRNA vaccine in elderly Ended
  2023-503800-99-00 Phase II 1 country TOZINAMERAN, FAMTOZINAMERAN
• A randomized trial investigating the superiority of TDM-optimized teicoplanin dosing versus standard of care Ended
  2023-503411-15-00 Phase IV 1 country TEICOPLANIN, TEICOPLANIN
• Digoxin for the Reinduction or Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Cancer. Ended
  2022-500477-14-00 Phase II 1 country DIGOXIN; SODIUM IODIDE (123 I)
• Lutetium-177-PSMA in Oligo-metastatic Hormone Sensitive Prostate Cancer. Ended
  2023-509881-39-00 Phase II 2 countries LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN

Showing 1–21 of 21 trials